← All trials
NCT06615752
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2024
- Primary completion
- Apr 30, 2028
- Completion date
- Feb 28, 2029
- First posted
- Sep 27, 2024
- Last posted
- Sep 27, 2024
- Enrollment
- 99
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Charles Drew UniversityLead sponsor
- Charles Drew UniversitySponsor investigator
- National Institutes of Health (NIH)Collaborator
- Charles Drew UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.